| References1Bates, D.W., et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. Journal of the American Medical Association 280(15):1311–1316, 1998. 2Institute of Medicine (IOM). Preventing Medication Errors: Quality Chasm Series. 2007. More information available at http://books.nap.edu/catalog/11623.html; accessed October 31, 2006. 3Markle Foundation. Connecting for Health. More information available at www.connectingforhealth.org; accessed October 31, 2006. 4U.S. Food and Drug Administration (FDA) MedWatch. More information available at www.fda.gov/ medwatch; accessed October 31, 2006. 5American Medical Association. Ask Me 3. More information available at www.askme3.org; accessed October 31, 2006. 6National Council on Patient Information and Education. Talk About Prescriptions. More information available at www.talkaboutrx.org; accessed October 31, 2006. 7FDA Workshop. "Streamlining the Blood Donor History Questionnaire." October 2000. More information available at www.fda.gov/cber/minutes/bldqstn101600.htm; accessed October 31, 2006. 8FDA Workshop. "Recruiting Blood Donors: Successful Practices." July 2000. More information available at www.fda.gov/ohrms/dockets/ac/00/backgrd/3649b2a.doc; accessed October 31, 2006. 9FDA Workshop. "Behavior-Based Donor Deferrals in the NAT Era." March 8, 2006. More information available at www.fda.gov/cber/minutes/nat030806t.htm; accessed October 31, 2006. 10Steering Committee for the Collaborative Development of a Long-Range Action Plan for the Provision of Useful Prescription Medicine Information. More information available at www.fda.gov/cder/offices/ods/keystone.pdf; accessed October 31, 2006. 11FDA. Guidance: Useful Written Consumer Medication Information (CMI). July 2006. More information available at www.fda.gov/cder/guidance/7139fnl.htm; accessed October 31, 2006. 12Thomson, R.A., et al. Retention of safe blood donors. Transfusion 38:359–367, 1998. 13Glynn, S.A., et al. Motivations to donate blood: Demographic comparisons. Transfusion 42(2):216–225, 2002. 14Executive Order: Incentives for the Use of Health Information Technology and Establishing the Position of the National Health Information Technology Coordinator. More information available at www.whitehouse.gov/news/releases/2004/04/20040427-4.html; accessed October 31, 2006. 15Agency for Healthcare Research and Quality. More information available at www.ahrq.gov/QUAL/rxtherapies/rxria.htm; accessed October 31, 2006. 16IOM. To Err Is Human: Building a Safer Health System. 2000. More information available at http://books.nap.edu/catalog/9728.html; accessed October 31, 2006. 17IOM. Crossing the Quality Chasm: A New Health System for the 21st Century. 2001. More information available at http://books.nap.edu/catalog/10027.html; accessed October 31, 2006. 18FDA. Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products. More information available at www.fda.gov/cber/gdlns/cjdvcjd.htm; accessed October 31, 2006. Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®. << Previous—Objectives and Subobjectives | Table of Contents | Next—Related Objectives From Other Focus Areas >> |